nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CA9—hematologic cancer	0.275	1	CbGaD
Diclofenamide—CA14—Imatinib—hematologic cancer	0.0431	0.0825	CbGbCtD
Diclofenamide—CA6—Imatinib—hematologic cancer	0.0409	0.0783	CbGbCtD
Diclofenamide—CA14—Nilotinib—hematologic cancer	0.0391	0.0749	CbGbCtD
Diclofenamide—CA6—Nilotinib—hematologic cancer	0.0372	0.0712	CbGbCtD
Diclofenamide—CA7—Imatinib—hematologic cancer	0.0357	0.0683	CbGbCtD
Diclofenamide—CA7—Nilotinib—hematologic cancer	0.0324	0.062	CbGbCtD
Diclofenamide—CA12—Imatinib—hematologic cancer	0.0306	0.0586	CbGbCtD
Diclofenamide—CA9—Imatinib—hematologic cancer	0.0306	0.0586	CbGbCtD
Diclofenamide—CA1—Imatinib—hematologic cancer	0.0286	0.0548	CbGbCtD
Diclofenamide—CA12—Nilotinib—hematologic cancer	0.0278	0.0532	CbGbCtD
Diclofenamide—CA9—Nilotinib—hematologic cancer	0.0278	0.0532	CbGbCtD
Diclofenamide—CA1—Nilotinib—hematologic cancer	0.026	0.0498	CbGbCtD
Diclofenamide—CA2—Imatinib—hematologic cancer	0.0247	0.0474	CbGbCtD
Diclofenamide—CA4—Nilotinib—hematologic cancer	0.0245	0.0468	CbGbCtD
Diclofenamide—CA2—Nilotinib—hematologic cancer	0.0225	0.043	CbGbCtD
Diclofenamide—CYP2C9—Bexarotene—hematologic cancer	0.00973	0.0186	CbGbCtD
Diclofenamide—CYP2C9—Idarubicin—hematologic cancer	0.00806	0.0154	CbGbCtD
Diclofenamide—CYP2C9—Bortezomib—hematologic cancer	0.00596	0.0114	CbGbCtD
Diclofenamide—CYP2C9—Thalidomide—hematologic cancer	0.0052	0.00995	CbGbCtD
Diclofenamide—CYP2C9—Teniposide—hematologic cancer	0.00496	0.00949	CbGbCtD
Diclofenamide—CYP2C9—Ifosfamide—hematologic cancer	0.00457	0.00876	CbGbCtD
Diclofenamide—CYP2C9—Imatinib—hematologic cancer	0.00437	0.00837	CbGbCtD
Diclofenamide—CYP2C9—Nilotinib—hematologic cancer	0.00397	0.0076	CbGbCtD
Diclofenamide—CYP2C9—Cisplatin—hematologic cancer	0.00223	0.00426	CbGbCtD
Diclofenamide—CYP2C9—Dexamethasone—hematologic cancer	0.0018	0.00344	CbGbCtD
Diclofenamide—CA5B—hematopoietic system—hematologic cancer	0.000725	0.0753	CbGeAlD
Diclofenamide—CA1—hematopoietic system—hematologic cancer	0.00064	0.0665	CbGeAlD
Diclofenamide—CA9—testis—hematologic cancer	0.000599	0.0622	CbGeAlD
Diclofenamide—CA5B—gonad—hematologic cancer	0.000551	0.0573	CbGeAlD
Diclofenamide—Hydrochlorothiazide—CA9—hematologic cancer	0.000513	0.529	CrCbGaD
Diclofenamide—CA5B—blood—hematologic cancer	0.00048	0.0499	CbGeAlD
Diclofenamide—CA12—lung—hematologic cancer	0.000469	0.0488	CbGeAlD
Diclofenamide—Trichlormethiazide—CA9—hematologic cancer	0.000457	0.471	CrCbGaD
Diclofenamide—CA1—blood—hematologic cancer	0.000424	0.0441	CbGeAlD
Diclofenamide—CA5B—lung—hematologic cancer	0.000421	0.0438	CbGeAlD
Diclofenamide—CA2—hematopoietic system—hematologic cancer	0.000415	0.0431	CbGeAlD
Diclofenamide—CA1—bone marrow—hematologic cancer	0.000411	0.0427	CbGeAlD
Diclofenamide—CA5B—testis—hematologic cancer	0.000397	0.0413	CbGeAlD
Diclofenamide—CA1—lung—hematologic cancer	0.000372	0.0386	CbGeAlD
Diclofenamide—CYP2C9—hematopoietic system—hematologic cancer	0.000351	0.0365	CbGeAlD
Diclofenamide—CA4—blood—hematologic cancer	0.000332	0.0345	CbGeAlD
Diclofenamide—CA4—bone marrow—hematologic cancer	0.000321	0.0333	CbGeAlD
Diclofenamide—CA4—lung—hematologic cancer	0.000291	0.0302	CbGeAlD
Diclofenamide—CA5B—lymph node—hematologic cancer	0.000288	0.0299	CbGeAlD
Diclofenamide—CA2—blood—hematologic cancer	0.000275	0.0286	CbGeAlD
Diclofenamide—CA4—testis—hematologic cancer	0.000274	0.0285	CbGeAlD
Diclofenamide—CA2—bone marrow—hematologic cancer	0.000266	0.0276	CbGeAlD
Diclofenamide—CA1—lymph node—hematologic cancer	0.000254	0.0264	CbGeAlD
Diclofenamide—CA2—lung—hematologic cancer	0.000241	0.025	CbGeAlD
Diclofenamide—CYP2C9—blood—hematologic cancer	0.000233	0.0242	CbGeAlD
Diclofenamide—CA2—testis—hematologic cancer	0.000227	0.0236	CbGeAlD
Diclofenamide—CA4—lymph node—hematologic cancer	0.000199	0.0207	CbGeAlD
Diclofenamide—CA2—lymph node—hematologic cancer	0.000165	0.0171	CbGeAlD
Diclofenamide—Constipation—Gemcitabine—hematologic cancer	6.37e-05	0.000441	CcSEcCtD
Diclofenamide—Body temperature increased—Ifosfamide—hematologic cancer	6.37e-05	0.000441	CcSEcCtD
Diclofenamide—Asthenia—Thiotepa—hematologic cancer	6.35e-05	0.00044	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—hematologic cancer	6.31e-05	0.000437	CcSEcCtD
Diclofenamide—Nausea—Melphalan—hematologic cancer	6.3e-05	0.000437	CcSEcCtD
Diclofenamide—Feeling abnormal—Mitoxantrone—hematologic cancer	6.3e-05	0.000436	CcSEcCtD
Diclofenamide—Feeling abnormal—Irinotecan—hematologic cancer	6.3e-05	0.000436	CcSEcCtD
Diclofenamide—Dizziness—Bortezomib—hematologic cancer	6.28e-05	0.000435	CcSEcCtD
Diclofenamide—Pruritus—Thiotepa—hematologic cancer	6.26e-05	0.000434	CcSEcCtD
Diclofenamide—Paraesthesia—Cisplatin—hematologic cancer	6.23e-05	0.000432	CcSEcCtD
Diclofenamide—Thrombocytopenia—Etoposide—hematologic cancer	6.23e-05	0.000431	CcSEcCtD
Diclofenamide—Body temperature increased—Vincristine—hematologic cancer	6.21e-05	0.00043	CcSEcCtD
Diclofenamide—Asthenia—Thalidomide—hematologic cancer	6.14e-05	0.000426	CcSEcCtD
Diclofenamide—Feeling abnormal—Gemcitabine—hematologic cancer	6.14e-05	0.000425	CcSEcCtD
Diclofenamide—Dizziness—Vinorelbine—hematologic cancer	6.13e-05	0.000425	CcSEcCtD
Diclofenamide—Nausea—Lenalidomide—hematologic cancer	6.13e-05	0.000425	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—hematologic cancer	6.11e-05	0.000423	CcSEcCtD
Diclofenamide—Anorexia—Etoposide—hematologic cancer	6.06e-05	0.00042	CcSEcCtD
Diclofenamide—Pruritus—Thalidomide—hematologic cancer	6.06e-05	0.00042	CcSEcCtD
Diclofenamide—Body temperature increased—Irinotecan—hematologic cancer	6.04e-05	0.000419	CcSEcCtD
Diclofenamide—Body temperature increased—Mitoxantrone—hematologic cancer	6.04e-05	0.000419	CcSEcCtD
Diclofenamide—Nausea—Hydroxyurea—hematologic cancer	6.04e-05	0.000419	CcSEcCtD
Diclofenamide—Vomiting—Bortezomib—hematologic cancer	6.04e-05	0.000418	CcSEcCtD
Diclofenamide—Decreased appetite—Cisplatin—hematologic cancer	6.04e-05	0.000418	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Cisplatin—hematologic cancer	5.99e-05	0.000415	CcSEcCtD
Diclofenamide—Vomiting—Bleomycin—hematologic cancer	5.99e-05	0.000415	CcSEcCtD
Diclofenamide—Rash—Bortezomib—hematologic cancer	5.99e-05	0.000415	CcSEcCtD
Diclofenamide—Drowsiness—Methotrexate—hematologic cancer	5.97e-05	0.000414	CcSEcCtD
Diclofenamide—Headache—Bortezomib—hematologic cancer	5.95e-05	0.000412	CcSEcCtD
Diclofenamide—Rash—Bleomycin—hematologic cancer	5.94e-05	0.000412	CcSEcCtD
Diclofenamide—Asthenia—Carmustine—hematologic cancer	5.9e-05	0.000409	CcSEcCtD
Diclofenamide—Vomiting—Vinorelbine—hematologic cancer	5.9e-05	0.000408	CcSEcCtD
Diclofenamide—Body temperature increased—Gemcitabine—hematologic cancer	5.89e-05	0.000408	CcSEcCtD
Diclofenamide—Dizziness—Thiotepa—hematologic cancer	5.86e-05	0.000406	CcSEcCtD
Diclofenamide—Asthenia—Alitretinoin—hematologic cancer	5.85e-05	0.000405	CcSEcCtD
Diclofenamide—Rash—Vinorelbine—hematologic cancer	5.85e-05	0.000405	CcSEcCtD
Diclofenamide—Headache—Vinorelbine—hematologic cancer	5.81e-05	0.000402	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—hematologic cancer	5.79e-05	0.000401	CcSEcCtD
Diclofenamide—Asthenia—Ifosfamide—hematologic cancer	5.78e-05	0.0004	CcSEcCtD
Diclofenamide—Pruritus—Alitretinoin—hematologic cancer	5.76e-05	0.000399	CcSEcCtD
Diclofenamide—Feeling abnormal—Cisplatin—hematologic cancer	5.72e-05	0.000396	CcSEcCtD
Diclofenamide—Paraesthesia—Etoposide—hematologic cancer	5.71e-05	0.000396	CcSEcCtD
Diclofenamide—Pruritus—Ifosfamide—hematologic cancer	5.7e-05	0.000395	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—hematologic cancer	5.67e-05	0.000393	CcSEcCtD
Diclofenamide—Dizziness—Thalidomide—hematologic cancer	5.66e-05	0.000392	CcSEcCtD
Diclofenamide—Somnolence—Etoposide—hematologic cancer	5.65e-05	0.000392	CcSEcCtD
Diclofenamide—Nausea—Bortezomib—hematologic cancer	5.64e-05	0.000391	CcSEcCtD
Diclofenamide—Asthenia—Vincristine—hematologic cancer	5.63e-05	0.00039	CcSEcCtD
Diclofenamide—Paraesthesia—Prednisolone—hematologic cancer	5.63e-05	0.00039	CcSEcCtD
Diclofenamide—Vomiting—Thiotepa—hematologic cancer	5.63e-05	0.00039	CcSEcCtD
Diclofenamide—Nausea—Bleomycin—hematologic cancer	5.6e-05	0.000388	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—hematologic cancer	5.59e-05	0.000387	CcSEcCtD
Diclofenamide—Rash—Thiotepa—hematologic cancer	5.58e-05	0.000387	CcSEcCtD
Diclofenamide—Agranulocytosis—Methotrexate—hematologic cancer	5.57e-05	0.000386	CcSEcCtD
Diclofenamide—Headache—Thiotepa—hematologic cancer	5.55e-05	0.000384	CcSEcCtD
Diclofenamide—Decreased appetite—Etoposide—hematologic cancer	5.53e-05	0.000383	CcSEcCtD
Diclofenamide—Nausea—Vinorelbine—hematologic cancer	5.51e-05	0.000381	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Etoposide—hematologic cancer	5.49e-05	0.00038	CcSEcCtD
Diclofenamide—Body temperature increased—Cisplatin—hematologic cancer	5.49e-05	0.00038	CcSEcCtD
Diclofenamide—Asthenia—Irinotecan—hematologic cancer	5.49e-05	0.00038	CcSEcCtD
Diclofenamide—Asthenia—Mitoxantrone—hematologic cancer	5.49e-05	0.00038	CcSEcCtD
Diclofenamide—Fatigue—Etoposide—hematologic cancer	5.48e-05	0.00038	CcSEcCtD
Diclofenamide—Vomiting—Thalidomide—hematologic cancer	5.45e-05	0.000377	CcSEcCtD
Diclofenamide—Dizziness—Carmustine—hematologic cancer	5.44e-05	0.000377	CcSEcCtD
Diclofenamide—Constipation—Etoposide—hematologic cancer	5.44e-05	0.000377	CcSEcCtD
Diclofenamide—Rash—Thalidomide—hematologic cancer	5.4e-05	0.000374	CcSEcCtD
Diclofenamide—Dizziness—Alitretinoin—hematologic cancer	5.39e-05	0.000373	CcSEcCtD
Diclofenamide—Headache—Thalidomide—hematologic cancer	5.37e-05	0.000372	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—hematologic cancer	5.36e-05	0.000371	CcSEcCtD
Diclofenamide—Asthenia—Gemcitabine—hematologic cancer	5.34e-05	0.00037	CcSEcCtD
Diclofenamide—Dizziness—Ifosfamide—hematologic cancer	5.33e-05	0.000369	CcSEcCtD
Diclofenamide—Pruritus—Gemcitabine—hematologic cancer	5.27e-05	0.000365	CcSEcCtD
Diclofenamide—Nausea—Thiotepa—hematologic cancer	5.26e-05	0.000364	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—hematologic cancer	5.25e-05	0.000364	CcSEcCtD
Diclofenamide—Feeling abnormal—Etoposide—hematologic cancer	5.24e-05	0.000363	CcSEcCtD
Diclofenamide—Vomiting—Carmustine—hematologic cancer	5.23e-05	0.000362	CcSEcCtD
Diclofenamide—Agranulocytosis—Epirubicin—hematologic cancer	5.22e-05	0.000361	CcSEcCtD
Diclofenamide—Dizziness—Vincristine—hematologic cancer	5.19e-05	0.00036	CcSEcCtD
Diclofenamide—Rash—Carmustine—hematologic cancer	5.19e-05	0.000359	CcSEcCtD
Diclofenamide—Vomiting—Alitretinoin—hematologic cancer	5.18e-05	0.000359	CcSEcCtD
Diclofenamide—Paraesthesia—Triamcinolone—hematologic cancer	5.18e-05	0.000359	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—hematologic cancer	5.17e-05	0.000358	CcSEcCtD
Diclofenamide—Feeling abnormal—Prednisolone—hematologic cancer	5.17e-05	0.000358	CcSEcCtD
Diclofenamide—Headache—Carmustine—hematologic cancer	5.15e-05	0.000357	CcSEcCtD
Diclofenamide—Rash—Alitretinoin—hematologic cancer	5.14e-05	0.000356	CcSEcCtD
Diclofenamide—Thrombocytopenia—Betamethasone—hematologic cancer	5.13e-05	0.000355	CcSEcCtD
Diclofenamide—Thrombocytopenia—Dexamethasone—hematologic cancer	5.13e-05	0.000355	CcSEcCtD
Diclofenamide—Vomiting—Ifosfamide—hematologic cancer	5.12e-05	0.000355	CcSEcCtD
Diclofenamide—Headache—Alitretinoin—hematologic cancer	5.1e-05	0.000354	CcSEcCtD
Diclofenamide—Nausea—Thalidomide—hematologic cancer	5.09e-05	0.000352	CcSEcCtD
Diclofenamide—Dyspepsia—Triamcinolone—hematologic cancer	5.08e-05	0.000352	CcSEcCtD
Diclofenamide—Rash—Ifosfamide—hematologic cancer	5.08e-05	0.000352	CcSEcCtD
Diclofenamide—Dizziness—Irinotecan—hematologic cancer	5.06e-05	0.00035	CcSEcCtD
Diclofenamide—Body temperature increased—Etoposide—hematologic cancer	5.03e-05	0.000348	CcSEcCtD
Diclofenamide—Tinnitus—Methotrexate—hematologic cancer	5e-05	0.000346	CcSEcCtD
Diclofenamide—Vomiting—Vincristine—hematologic cancer	4.99e-05	0.000346	CcSEcCtD
Diclofenamide—Anorexia—Betamethasone—hematologic cancer	4.99e-05	0.000346	CcSEcCtD
Diclofenamide—Anorexia—Dexamethasone—hematologic cancer	4.99e-05	0.000346	CcSEcCtD
Diclofenamide—Asthenia—Cisplatin—hematologic cancer	4.98e-05	0.000345	CcSEcCtD
Diclofenamide—Fatigue—Triamcinolone—hematologic cancer	4.97e-05	0.000345	CcSEcCtD
Diclofenamide—Rash—Vincristine—hematologic cancer	4.95e-05	0.000343	CcSEcCtD
Diclofenamide—Headache—Vincristine—hematologic cancer	4.92e-05	0.000341	CcSEcCtD
Diclofenamide—Nausea—Carmustine—hematologic cancer	4.89e-05	0.000338	CcSEcCtD
Diclofenamide—Vomiting—Irinotecan—hematologic cancer	4.86e-05	0.000337	CcSEcCtD
Diclofenamide—Vomiting—Mitoxantrone—hematologic cancer	4.86e-05	0.000337	CcSEcCtD
Diclofenamide—Nausea—Alitretinoin—hematologic cancer	4.84e-05	0.000335	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—hematologic cancer	4.83e-05	0.000334	CcSEcCtD
Diclofenamide—Rash—Mitoxantrone—hematologic cancer	4.82e-05	0.000334	CcSEcCtD
Diclofenamide—Rash—Irinotecan—hematologic cancer	4.82e-05	0.000334	CcSEcCtD
Diclofenamide—Headache—Mitoxantrone—hematologic cancer	4.79e-05	0.000332	CcSEcCtD
Diclofenamide—Headache—Irinotecan—hematologic cancer	4.79e-05	0.000332	CcSEcCtD
Diclofenamide—Nausea—Ifosfamide—hematologic cancer	4.78e-05	0.000331	CcSEcCtD
Diclofenamide—Feeling abnormal—Triamcinolone—hematologic cancer	4.75e-05	0.000329	CcSEcCtD
Diclofenamide—Vomiting—Gemcitabine—hematologic cancer	4.74e-05	0.000328	CcSEcCtD
Diclofenamide—Paraesthesia—Betamethasone—hematologic cancer	4.7e-05	0.000326	CcSEcCtD
Diclofenamide—Paraesthesia—Dexamethasone—hematologic cancer	4.7e-05	0.000326	CcSEcCtD
Diclofenamide—Rash—Gemcitabine—hematologic cancer	4.7e-05	0.000325	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—hematologic cancer	4.68e-05	0.000324	CcSEcCtD
Diclofenamide—Headache—Gemcitabine—hematologic cancer	4.67e-05	0.000323	CcSEcCtD
Diclofenamide—Nausea—Vincristine—hematologic cancer	4.66e-05	0.000323	CcSEcCtD
Diclofenamide—Dyspepsia—Dexamethasone—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Diclofenamide—Dyspepsia—Betamethasone—hematologic cancer	4.61e-05	0.000319	CcSEcCtD
Diclofenamide—Asthenia—Etoposide—hematologic cancer	4.56e-05	0.000316	CcSEcCtD
Diclofenamide—Body temperature increased—Triamcinolone—hematologic cancer	4.56e-05	0.000316	CcSEcCtD
Diclofenamide—Decreased appetite—Betamethasone—hematologic cancer	4.55e-05	0.000315	CcSEcCtD
Diclofenamide—Decreased appetite—Dexamethasone—hematologic cancer	4.55e-05	0.000315	CcSEcCtD
Diclofenamide—Nausea—Mitoxantrone—hematologic cancer	4.54e-05	0.000315	CcSEcCtD
Diclofenamide—Nausea—Irinotecan—hematologic cancer	4.54e-05	0.000315	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.52e-05	0.000313	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.52e-05	0.000313	CcSEcCtD
Diclofenamide—Fatigue—Dexamethasone—hematologic cancer	4.51e-05	0.000313	CcSEcCtD
Diclofenamide—Fatigue—Betamethasone—hematologic cancer	4.51e-05	0.000313	CcSEcCtD
Diclofenamide—Pruritus—Etoposide—hematologic cancer	4.5e-05	0.000312	CcSEcCtD
Diclofenamide—Nausea—Gemcitabine—hematologic cancer	4.42e-05	0.000306	CcSEcCtD
Diclofenamide—Vomiting—Cisplatin—hematologic cancer	4.41e-05	0.000306	CcSEcCtD
Diclofenamide—Rash—Cisplatin—hematologic cancer	4.38e-05	0.000303	CcSEcCtD
Diclofenamide—Anorexia—Prednisone—hematologic cancer	4.35e-05	0.000301	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—hematologic cancer	4.33e-05	0.0003	CcSEcCtD
Diclofenamide—Feeling abnormal—Betamethasone—hematologic cancer	4.31e-05	0.000299	CcSEcCtD
Diclofenamide—Feeling abnormal—Dexamethasone—hematologic cancer	4.31e-05	0.000299	CcSEcCtD
Diclofenamide—Tension—Epirubicin—hematologic cancer	4.29e-05	0.000297	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—hematologic cancer	4.24e-05	0.000294	CcSEcCtD
Diclofenamide—Dizziness—Etoposide—hematologic cancer	4.21e-05	0.000291	CcSEcCtD
Diclofenamide—Leukopenia—Methotrexate—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Diclofenamide—Dizziness—Prednisolone—hematologic cancer	4.15e-05	0.000287	CcSEcCtD
Diclofenamide—Asthenia—Triamcinolone—hematologic cancer	4.14e-05	0.000287	CcSEcCtD
Diclofenamide—Body temperature increased—Dexamethasone—hematologic cancer	4.14e-05	0.000287	CcSEcCtD
Diclofenamide—Body temperature increased—Betamethasone—hematologic cancer	4.14e-05	0.000287	CcSEcCtD
Diclofenamide—Nausea—Cisplatin—hematologic cancer	4.12e-05	0.000286	CcSEcCtD
Diclofenamide—Paraesthesia—Prednisone—hematologic cancer	4.09e-05	0.000284	CcSEcCtD
Diclofenamide—Pruritus—Triamcinolone—hematologic cancer	4.08e-05	0.000283	CcSEcCtD
Diclofenamide—Vomiting—Etoposide—hematologic cancer	4.04e-05	0.00028	CcSEcCtD
Diclofenamide—Dyspepsia—Prednisone—hematologic cancer	4.01e-05	0.000278	CcSEcCtD
Diclofenamide—Rash—Etoposide—hematologic cancer	4.01e-05	0.000278	CcSEcCtD
Diclofenamide—Headache—Etoposide—hematologic cancer	3.98e-05	0.000276	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—hematologic cancer	3.97e-05	0.000275	CcSEcCtD
Diclofenamide—Decreased appetite—Prednisone—hematologic cancer	3.96e-05	0.000274	CcSEcCtD
Diclofenamide—Rash—Prednisolone—hematologic cancer	3.96e-05	0.000274	CcSEcCtD
Diclofenamide—Fatigue—Prednisone—hematologic cancer	3.93e-05	0.000272	CcSEcCtD
Diclofenamide—Headache—Prednisolone—hematologic cancer	3.93e-05	0.000272	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—hematologic cancer	3.93e-05	0.000272	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—hematologic cancer	3.91e-05	0.000271	CcSEcCtD
Diclofenamide—Constipation—Prednisone—hematologic cancer	3.9e-05	0.00027	CcSEcCtD
Diclofenamide—Confusional state—Methotrexate—hematologic cancer	3.84e-05	0.000266	CcSEcCtD
Diclofenamide—Dizziness—Triamcinolone—hematologic cancer	3.81e-05	0.000264	CcSEcCtD
Diclofenamide—Nausea—Etoposide—hematologic cancer	3.78e-05	0.000262	CcSEcCtD
Diclofenamide—Feeling abnormal—Prednisone—hematologic cancer	3.76e-05	0.00026	CcSEcCtD
Diclofenamide—Asthenia—Dexamethasone—hematologic cancer	3.76e-05	0.00026	CcSEcCtD
Diclofenamide—Asthenia—Betamethasone—hematologic cancer	3.76e-05	0.00026	CcSEcCtD
Diclofenamide—Thrombocytopenia—Methotrexate—hematologic cancer	3.73e-05	0.000258	CcSEcCtD
Diclofenamide—Nausea—Prednisolone—hematologic cancer	3.73e-05	0.000258	CcSEcCtD
Diclofenamide—Pruritus—Dexamethasone—hematologic cancer	3.7e-05	0.000257	CcSEcCtD
Diclofenamide—Pruritus—Betamethasone—hematologic cancer	3.7e-05	0.000257	CcSEcCtD
Diclofenamide—Vomiting—Triamcinolone—hematologic cancer	3.67e-05	0.000254	CcSEcCtD
Diclofenamide—Rash—Triamcinolone—hematologic cancer	3.64e-05	0.000252	CcSEcCtD
Diclofenamide—Anorexia—Methotrexate—hematologic cancer	3.63e-05	0.000252	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—hematologic cancer	3.62e-05	0.000251	CcSEcCtD
Diclofenamide—Headache—Triamcinolone—hematologic cancer	3.61e-05	0.00025	CcSEcCtD
Diclofenamide—Body temperature increased—Prednisone—hematologic cancer	3.6e-05	0.00025	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—hematologic cancer	3.59e-05	0.000249	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—hematologic cancer	3.49e-05	0.000242	CcSEcCtD
Diclofenamide—Dizziness—Betamethasone—hematologic cancer	3.46e-05	0.00024	CcSEcCtD
Diclofenamide—Dizziness—Dexamethasone—hematologic cancer	3.46e-05	0.00024	CcSEcCtD
Diclofenamide—Nausea—Triamcinolone—hematologic cancer	3.43e-05	0.000237	CcSEcCtD
Diclofenamide—Paraesthesia—Methotrexate—hematologic cancer	3.42e-05	0.000237	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—hematologic cancer	3.4e-05	0.000235	CcSEcCtD
Diclofenamide—Somnolence—Methotrexate—hematologic cancer	3.39e-05	0.000235	CcSEcCtD
Diclofenamide—Dyspepsia—Methotrexate—hematologic cancer	3.35e-05	0.000232	CcSEcCtD
Diclofenamide—Vomiting—Dexamethasone—hematologic cancer	3.33e-05	0.000231	CcSEcCtD
Diclofenamide—Vomiting—Betamethasone—hematologic cancer	3.33e-05	0.000231	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—hematologic cancer	3.33e-05	0.00023	CcSEcCtD
Diclofenamide—Decreased appetite—Methotrexate—hematologic cancer	3.31e-05	0.000229	CcSEcCtD
Diclofenamide—Rash—Dexamethasone—hematologic cancer	3.3e-05	0.000229	CcSEcCtD
Diclofenamide—Rash—Betamethasone—hematologic cancer	3.3e-05	0.000229	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.29e-05	0.000228	CcSEcCtD
Diclofenamide—Fatigue—Methotrexate—hematologic cancer	3.28e-05	0.000228	CcSEcCtD
Diclofenamide—Headache—Betamethasone—hematologic cancer	3.28e-05	0.000227	CcSEcCtD
Diclofenamide—Headache—Dexamethasone—hematologic cancer	3.28e-05	0.000227	CcSEcCtD
Diclofenamide—Asthenia—Prednisone—hematologic cancer	3.27e-05	0.000227	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—hematologic cancer	3.23e-05	0.000224	CcSEcCtD
Diclofenamide—Pruritus—Prednisone—hematologic cancer	3.23e-05	0.000223	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—hematologic cancer	3.2e-05	0.000222	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—hematologic cancer	3.17e-05	0.00022	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—hematologic cancer	3.14e-05	0.000218	CcSEcCtD
Diclofenamide—Feeling abnormal—Methotrexate—hematologic cancer	3.14e-05	0.000217	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—hematologic cancer	3.14e-05	0.000217	CcSEcCtD
Diclofenamide—Nausea—Dexamethasone—hematologic cancer	3.11e-05	0.000215	CcSEcCtD
Diclofenamide—Nausea—Betamethasone—hematologic cancer	3.11e-05	0.000215	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—hematologic cancer	3.1e-05	0.000215	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.08e-05	0.000213	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—hematologic cancer	3.07e-05	0.000213	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—hematologic cancer	3.05e-05	0.000211	CcSEcCtD
Diclofenamide—Dizziness—Prednisone—hematologic cancer	3.01e-05	0.000209	CcSEcCtD
Diclofenamide—Body temperature increased—Methotrexate—hematologic cancer	3.01e-05	0.000209	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—hematologic cancer	2.96e-05	0.000205	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—hematologic cancer	2.94e-05	0.000203	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—hematologic cancer	2.93e-05	0.000203	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—hematologic cancer	2.9e-05	0.000201	CcSEcCtD
Diclofenamide—Vomiting—Prednisone—hematologic cancer	2.9e-05	0.000201	CcSEcCtD
Diclofenamide—Rash—Prednisone—hematologic cancer	2.87e-05	0.000199	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—hematologic cancer	2.87e-05	0.000199	CcSEcCtD
Diclofenamide—Headache—Prednisone—hematologic cancer	2.86e-05	0.000198	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.85e-05	0.000197	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—hematologic cancer	2.84e-05	0.000197	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—hematologic cancer	2.82e-05	0.000195	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—hematologic cancer	2.82e-05	0.000195	CcSEcCtD
Diclofenamide—Asthenia—Methotrexate—hematologic cancer	2.73e-05	0.000189	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—hematologic cancer	2.72e-05	0.000188	CcSEcCtD
Diclofenamide—Nausea—Prednisone—hematologic cancer	2.71e-05	0.000188	CcSEcCtD
Diclofenamide—Pruritus—Methotrexate—hematologic cancer	2.7e-05	0.000187	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—hematologic cancer	2.61e-05	0.000181	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—hematologic cancer	2.56e-05	0.000177	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—hematologic cancer	2.52e-05	0.000175	CcSEcCtD
Diclofenamide—Dizziness—Methotrexate—hematologic cancer	2.52e-05	0.000174	CcSEcCtD
Diclofenamide—Vomiting—Methotrexate—hematologic cancer	2.42e-05	0.000168	CcSEcCtD
Diclofenamide—Rash—Methotrexate—hematologic cancer	2.4e-05	0.000166	CcSEcCtD
Diclofenamide—Headache—Methotrexate—hematologic cancer	2.39e-05	0.000165	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—hematologic cancer	2.37e-05	0.000164	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—hematologic cancer	2.36e-05	0.000163	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—hematologic cancer	2.33e-05	0.000162	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—hematologic cancer	2.27e-05	0.000157	CcSEcCtD
Diclofenamide—Nausea—Methotrexate—hematologic cancer	2.26e-05	0.000157	CcSEcCtD
Diclofenamide—Rash—Epirubicin—hematologic cancer	2.25e-05	0.000156	CcSEcCtD
Diclofenamide—Headache—Epirubicin—hematologic cancer	2.23e-05	0.000155	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—hematologic cancer	2.18e-05	0.000151	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—hematologic cancer	2.12e-05	0.000147	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—hematologic cancer	2.1e-05	0.000145	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—hematologic cancer	2.08e-05	0.000144	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—hematologic cancer	2.07e-05	0.000143	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—hematologic cancer	1.96e-05	0.000136	CcSEcCtD
Diclofenamide—CA5A—Metabolism—GSTM1—hematologic cancer	1.7e-05	0.000356	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NCOR1—hematologic cancer	1.7e-05	0.000356	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTT1—hematologic cancer	1.7e-05	0.000355	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NUP98—hematologic cancer	1.66e-05	0.000347	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SDC1—hematologic cancer	1.66e-05	0.000347	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—MAPK3—hematologic cancer	1.66e-05	0.000346	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000343	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000343	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ADCY7—hematologic cancer	1.61e-05	0.000337	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NCOA3—hematologic cancer	1.61e-05	0.000337	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTP1—hematologic cancer	1.6e-05	0.000335	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NUP214—hematologic cancer	1.6e-05	0.000335	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NCOR1—hematologic cancer	1.59e-05	0.000333	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTM1—hematologic cancer	1.59e-05	0.000333	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTM1—hematologic cancer	1.59e-05	0.000333	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NCOR1—hematologic cancer	1.59e-05	0.000333	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ABCG2—hematologic cancer	1.57e-05	0.000328	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTR—hematologic cancer	1.57e-05	0.000328	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—MTHFR—hematologic cancer	1.55e-05	0.000323	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTP1—hematologic cancer	1.54e-05	0.000323	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ENO2—hematologic cancer	1.54e-05	0.000321	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CD44—hematologic cancer	1.53e-05	0.000321	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NQO1—hematologic cancer	1.53e-05	0.000321	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTP1—hematologic cancer	1.52e-05	0.000318	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ABCB1—hematologic cancer	1.52e-05	0.000317	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—MTHFR—hematologic cancer	1.51e-05	0.000315	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—MTHFR—hematologic cancer	1.51e-05	0.000315	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTT1—hematologic cancer	1.49e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NCOR1—hematologic cancer	1.47e-05	0.000308	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTM1—hematologic cancer	1.47e-05	0.000308	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CD44—hematologic cancer	1.47e-05	0.000307	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NQO1—hematologic cancer	1.47e-05	0.000307	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SDC1—hematologic cancer	1.46e-05	0.000305	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYCS—hematologic cancer	1.45e-05	0.000303	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HSP90AA1—hematologic cancer	1.44e-05	0.000301	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTM1—hematologic cancer	1.42e-05	0.000296	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CD44—hematologic cancer	1.41e-05	0.000295	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NQO1—hematologic cancer	1.41e-05	0.000295	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—MTHFR—hematologic cancer	1.41e-05	0.000294	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—MTHFR—hematologic cancer	1.41e-05	0.000294	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTM1—hematologic cancer	1.4e-05	0.000292	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.39e-05	0.000292	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYCS—hematologic cancer	1.39e-05	0.000291	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HSP90AA1—hematologic cancer	1.38e-05	0.000289	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYCS—hematologic cancer	1.33e-05	0.000279	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HSP90AA1—hematologic cancer	1.33e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—TP53—hematologic cancer	1.32e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—MTHFR—hematologic cancer	1.3e-05	0.000272	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CG—hematologic cancer	1.3e-05	0.000272	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTP1—hematologic cancer	1.28e-05	0.000267	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CG—hematologic cancer	1.27e-05	0.000265	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CG—hematologic cancer	1.27e-05	0.000265	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CD44—hematologic cancer	1.24e-05	0.000259	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NQO1—hematologic cancer	1.24e-05	0.000259	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTP1—hematologic cancer	1.23e-05	0.000256	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.22e-05	0.000255	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—IL6—hematologic cancer	1.21e-05	0.000253	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ABCB1—hematologic cancer	1.21e-05	0.000253	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CREBBP—hematologic cancer	1.2e-05	0.000252	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—FTCD—hematologic cancer	1.18e-05	0.000247	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PHYH—hematologic cancer	1.18e-05	0.000247	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GMPS—hematologic cancer	1.18e-05	0.000247	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000247	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000247	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTP1—hematologic cancer	1.18e-05	0.000246	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—hematologic cancer	1.18e-05	0.000246	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NCOR1—hematologic cancer	1.18e-05	0.000246	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CREBBP—hematologic cancer	1.17e-05	0.000245	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CREBBP—hematologic cancer	1.17e-05	0.000245	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYCS—hematologic cancer	1.17e-05	0.000245	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.17e-05	0.000245	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HSP90AA1—hematologic cancer	1.17e-05	0.000244	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ABCB1—hematologic cancer	1.16e-05	0.000243	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CD—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ALB—hematologic cancer	1.13e-05	0.000236	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NCOR1—hematologic cancer	1.13e-05	0.000236	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—hematologic cancer	1.13e-05	0.000236	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.12e-05	0.000233	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ABCB1—hematologic cancer	1.11e-05	0.000233	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CD—hematologic cancer	1.11e-05	0.000233	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CD—hematologic cancer	1.11e-05	0.000233	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.1e-05	0.00023	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ALB—hematologic cancer	1.1e-05	0.00023	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ALB—hematologic cancer	1.1e-05	0.00023	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CREBBP—hematologic cancer	1.1e-05	0.000229	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CREBBP—hematologic cancer	1.1e-05	0.000229	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CG—hematologic cancer	1.09e-05	0.000229	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SMPD3—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NCOR1—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3R1—hematologic cancer	1.08e-05	0.000225	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3R1—hematologic cancer	1.05e-05	0.00022	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3R1—hematologic cancer	1.05e-05	0.00022	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—hematologic cancer	1.04e-05	0.000217	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000217	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000217	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTP1—hematologic cancer	1.03e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ALB—hematologic cancer	1.03e-05	0.000214	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ALB—hematologic cancer	1.03e-05	0.000214	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CREBBP—hematologic cancer	1.02e-05	0.000212	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.01e-05	0.000211	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—hematologic cancer	9.96e-06	0.000208	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CB—hematologic cancer	9.95e-06	0.000208	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	9.83e-06	0.000205	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3R1—hematologic cancer	9.81e-06	0.000205	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3R1—hematologic cancer	9.81e-06	0.000205	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ABCB1—hematologic cancer	9.79e-06	0.000205	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CB—hematologic cancer	9.7e-06	0.000203	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CB—hematologic cancer	9.7e-06	0.000203	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CD—hematologic cancer	9.63e-06	0.000201	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—hematologic cancer	9.55e-06	0.0002	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—hematologic cancer	9.5e-06	0.000199	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NCOR1—hematologic cancer	9.5e-06	0.000199	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ALB—hematologic cancer	9.5e-06	0.000199	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ASNS—hematologic cancer	9.45e-06	0.000198	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—B3GAT1—hematologic cancer	9.45e-06	0.000198	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—DCK—hematologic cancer	9.45e-06	0.000198	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	9.24e-06	0.000193	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3R1—hematologic cancer	9.09e-06	0.00019	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CB—hematologic cancer	9.06e-06	0.000189	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CB—hematologic cancer	9.06e-06	0.000189	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HDC—hematologic cancer	8.96e-06	0.000187	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CG—hematologic cancer	8.73e-06	0.000182	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTEN—hematologic cancer	8.6e-06	0.00018	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—hematologic cancer	8.4e-06	0.000176	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CB—hematologic cancer	8.39e-06	0.000175	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTEN—hematologic cancer	8.38e-06	0.000175	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTEN—hematologic cancer	8.38e-06	0.000175	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CG—hematologic cancer	8.37e-06	0.000175	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	8.36e-06	0.000175	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—EP300—hematologic cancer	8.2e-06	0.000171	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CDA—hematologic cancer	8.2e-06	0.000171	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CREBBP—hematologic cancer	8.1e-06	0.000169	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CG—hematologic cancer	8.03e-06	0.000168	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—EP300—hematologic cancer	7.99e-06	0.000167	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—EP300—hematologic cancer	7.99e-06	0.000167	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PC—hematologic cancer	7.89e-06	0.000165	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTEN—hematologic cancer	7.83e-06	0.000164	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTEN—hematologic cancer	7.83e-06	0.000164	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CREBBP—hematologic cancer	7.76e-06	0.000162	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CD—hematologic cancer	7.68e-06	0.00016	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GBA—hematologic cancer	7.62e-06	0.000159	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC35B2—hematologic cancer	7.62e-06	0.000159	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ALB—hematologic cancer	7.58e-06	0.000158	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—EP300—hematologic cancer	7.46e-06	0.000156	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—EP300—hematologic cancer	7.46e-06	0.000156	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CREBBP—hematologic cancer	7.44e-06	0.000156	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CD—hematologic cancer	7.36e-06	0.000154	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ALB—hematologic cancer	7.26e-06	0.000152	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTEN—hematologic cancer	7.25e-06	0.000152	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3R1—hematologic cancer	7.25e-06	0.000151	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CG—hematologic cancer	7.06e-06	0.000147	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CD—hematologic cancer	7.06e-06	0.000147	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTAP—hematologic cancer	6.97e-06	0.000146	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ALB—hematologic cancer	6.96e-06	0.000146	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3R1—hematologic cancer	6.95e-06	0.000145	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—EP300—hematologic cancer	6.91e-06	0.000144	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CB—hematologic cancer	6.69e-06	0.00014	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3R1—hematologic cancer	6.66e-06	0.000139	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CREBBP—hematologic cancer	6.54e-06	0.000137	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CB—hematologic cancer	6.41e-06	0.000134	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—FHL2—hematologic cancer	6.21e-06	0.00013	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CD—hematologic cancer	6.2e-06	0.00013	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CB—hematologic cancer	6.15e-06	0.000129	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALB—hematologic cancer	6.12e-06	0.000128	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AGRN—hematologic cancer	6.09e-06	0.000127	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CA—hematologic cancer	6.07e-06	0.000127	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CA—hematologic cancer	5.91e-06	0.000124	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CA—hematologic cancer	5.91e-06	0.000124	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3R1—hematologic cancer	5.86e-06	0.000122	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTEN—hematologic cancer	5.78e-06	0.000121	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMMR—hematologic cancer	5.78e-06	0.000121	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—IDH2—hematologic cancer	5.78e-06	0.000121	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTEN—hematologic cancer	5.54e-06	0.000116	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CA—hematologic cancer	5.52e-06	0.000115	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CA—hematologic cancer	5.52e-06	0.000115	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—EP300—hematologic cancer	5.51e-06	0.000115	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.45e-06	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	5.43e-06	0.000113	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CB—hematologic cancer	5.41e-06	0.000113	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTEN—hematologic cancer	5.31e-06	0.000111	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—EP300—hematologic cancer	5.29e-06	0.00011	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACP5—hematologic cancer	5.28e-06	0.00011	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CA9—hematologic cancer	5.28e-06	0.00011	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	5.21e-06	0.000109	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CA—hematologic cancer	5.11e-06	0.000107	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—EP300—hematologic cancer	5.07e-06	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—IDH1—hematologic cancer	4.97e-06	0.000104	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKT1—hematologic cancer	4.96e-06	0.000104	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.91e-06	0.000103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TXN—hematologic cancer	4.91e-06	0.000103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.91e-06	0.000103	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKT1—hematologic cancer	4.83e-06	0.000101	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKT1—hematologic cancer	4.83e-06	0.000101	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.81e-06	0.0001	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTEN—hematologic cancer	4.67e-06	9.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4.62e-06	9.65e-05	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKT1—hematologic cancer	4.51e-06	9.43e-05	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKT1—hematologic cancer	4.51e-06	9.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.49e-06	9.39e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.49e-06	9.39e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—EP300—hematologic cancer	4.46e-06	9.31e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.38e-06	9.15e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NUP98—hematologic cancer	4.24e-06	8.86e-05	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKT1—hematologic cancer	4.18e-06	8.73e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.12e-06	8.6e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.12e-06	8.6e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NUP214—hematologic cancer	4.09e-06	8.54e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CA—hematologic cancer	4.08e-06	8.52e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.04e-06	8.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTR—hematologic cancer	4e-06	8.37e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	4e-06	8.37e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ENO2—hematologic cancer	3.93e-06	8.21e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CA—hematologic cancer	3.91e-06	8.17e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.81e-06	7.96e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.75e-06	7.84e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CA—hematologic cancer	3.75e-06	7.84e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SDC1—hematologic cancer	3.72e-06	7.78e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.55e-06	7.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.51e-06	7.33e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.36e-06	7.02e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKT1—hematologic cancer	3.33e-06	6.96e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CA—hematologic cancer	3.3e-06	6.89e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKT1—hematologic cancer	3.19e-06	6.68e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CD44—hematologic cancer	3.16e-06	6.61e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NQO1—hematologic cancer	3.16e-06	6.61e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.1e-06	6.48e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKT1—hematologic cancer	3.06e-06	6.4e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYCS—hematologic cancer	2.99e-06	6.26e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.98e-06	6.22e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKT1—hematologic cancer	2.69e-06	5.63e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.68e-06	5.6e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.64e-06	5.52e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.55e-06	5.34e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.5e-06	5.22e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.43e-06	5.07e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.43e-06	5.07e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.14e-06	4.48e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.89e-06	3.95e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.8e-06	3.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.67e-06	3.49e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.58e-06	3.31e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALB—hematologic cancer	1.56e-06	3.27e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.49e-06	3.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.38e-06	2.88e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTEN—hematologic cancer	1.19e-06	2.49e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—EP300—hematologic cancer	1.14e-06	2.38e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.41e-07	1.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKT1—hematologic cancer	6.87e-07	1.44e-05	CbGpPWpGaD
